arrow_back Trending Legislation
Share share

Lower Drug Costs for Low-Income Medicare Beneficiaries

This bill aims to reduce prescription drug costs for low-income individuals enrolled in Medicare Part D. Starting in 2024, copayments for generic drugs will be eliminated, and copayments for other drugs will be frozen at 2023 levels, with minor adjustments thereafter. This will help seniors and those with lower incomes pay less for their prescriptions, improving access to essential medications.
Key points
Beginning in 2024, low-income individuals in Medicare Part D will pay $0 for generic drugs.
Copayments for other drugs under Medicare Part D for low-income individuals will be frozen at 2023 levels, with future increases tied only to inflation.
These changes are designed to ease the financial burden of prescription drug costs for the most vulnerable Medicare beneficiaries.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Cutting Copays Act
Print number: HR 5386
Sponsor: Rep. McGarvey, Morgan [D-KY-3]
Process start date: 2023-09-12
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Lower Drug Costs for Low-Income Medicare Beneficiaries

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 5386.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-09-12.

What are the main provisions?

Key points include:

  • Beginning in 2024, low-income individuals in Medicare Part D will pay $0 for generic drugs.
  • Copayments for other drugs under Medicare Part D for low-income individuals will be frozen at 2023 levels, with future increases tied only to inflation.
  • These changes are designed to ease the financial burden of prescription drug costs for the most vulnerable Medicare beneficiaries.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. McGarvey, Morgan [D-KY-3].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 5386

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Benefits